The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia.
暂无分享,去创建一个
A. Hillman | J. Oesterling | C. Roehrborn | J. Schwartz | E. Peskin | P. Deverka | M. K. Willian | R. Padley | C. Maurath | M. Mason | J. E. Oesterling | C. G. Roehrborn | Alan L. Hillman | Ellen Peskin | Michael E. Mason | Clem J. Maurath | Patricia A. Deverka